Decision letter for "Nanoplatform-Mediated Metabolic Reprogramming to Overcome Resistance Mechanisms in Antitumor Therapies"
Fields of Study & Subjects
Nanoparticle-Based Drug Delivery
Drug Transport and Resistance Mechanisms
Cancer
Hypoxia
and Metabolism
Publication details
- Publication date
- 6 February 2026